ARCHIVES

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Funding opportunities listed.

January 16, 2004

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

In Brief: Forget Hew – It’s No HHS; Cancer Control Advisory Committee Meeting Set For Oct. 22

October 5, 1979